Systech Launches UniSecure artAI, an AI-Powered Authentication Solution for the Life Sciences and Pharmaceutical Industries

Rhea-AI Summary

Systech, a Dover company, has launched UniSecure artAI™, an AI-powered authentication solution for life sciences and pharmaceutical industries. This cloud-based SaaS solution utilizes existing packaging artwork and AI applications including machine vision, machine learning, and neural networks to combat counterfeiting and ensure packaging quality.

The solution addresses the growing challenge of counterfeit medicine trafficking, which generates up to $432 billion annually according to NIH. artAI creates digital blueprints of packaging artwork features for verification and quality inspection through pattern recognition, offering both mobile application scanning and forensic platform capabilities.

Key features include fast deployment with real-time detection, AI-powered forensic intelligence, retroactive and proactive protection, and reduced carbon footprint through centralized operations. The system requires no packaging changes or hardware integration, enabling rapid deployment and immediate value for pharmaceutical brands.

Positive

• Cloud-based SaaS solution requires no hardware integration or packaging changes
• Addresses $432B counterfeit medicine market opportunity
• Dual functionality: counterfeit detection and quality control
• Cost-efficient: reduces resources needed for quality inspection and forensic analysis

Negative

• None.

News Market Reaction

-0.59%

1 alert

-0.59% News Effect

On the day this news was published, DOV declined 0.59%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

DOWNERS GROVE, Ill., Feb. 26, 2025 /PRNewswire/ -- Systech, part of Markem-Imaje and Dover and a leading provider of digital identification and traceability software solutions, today announced the launch of UniSecure artAI™, a transformative AI-powered authentication solution designed to safeguard brands, ensure packaging quality and protect patients. As a fully cloud-based Software as a Service (SaaS) solution, artAI leverages existing packaging artwork and AI applications — like machine vision, machine learning and neural networks — to deliver real-time results and forensic analytics that help combat critical challenges for life sciences companies and pharmaceutical brands. 

"We are thrilled to introduce artAI, a ground-breaking offering that underscores our commitment to providing cutting-edge solutions to challenges ranging from counterfeiting and diversion to upholding the highest level of quality," said Sreedhar Patnala, General Manager, Systech. "artAI enables brands to quickly identify and resolve issues and roll out packaging quality checks and counterfeit protection at scale. It is easy to use, does not require packaging changes, can be deployed rapidly and provides immediate value."

Counterfeit medicine trafficking is one of the world's fastest-growing criminal enterprises, with the illicit, fraudulent or substandard drug market generating up to an estimated $432 billion each year, according to the National Institutes of Health. Brands also face the challenge of false counterfeits due to flaws in packaging quality inspection. artAI serves dual functionality by enabling detection of these issues before the product is shipped and delivering corrective analytics for quality control.

artAI uses advanced machine vision and machine learning to create a digital blueprint of key packaging artwork features, enabling precise verification and quality inspection through pattern recognition. The solution includes an easy-to-use mobile application for simple product scanning and a robust forensic platform to quickly get to the root of the problem. With advanced analytics and reporting, artAI significantly reduces the resources required to identify and resolve critical issues.

Key benefits:

• Fast deployment & real-time detection: Uses existing packaging to inspect products immediately; no hardware integration required.
• Unparalleled forensic intelligence: AI-powered forensic tools and reporting provide extensive data to investigate packaging issues and supply chain threats while providing actionable, robust analytics.
• Retroactive & proactive protection: Products already in the marketplace are automatically protected under the brand protection program, while production inline applications for quality inspection provide coverage before products are shipped.
• Carbon footprint reduction: A centralized platform removes the need to ship physical samples or deploy additional forensic resources.

With artAI, brand protection and quality assurance teams can digitize processes, significantly reduce resources and enable rapid return on their investment while keeping patients safe. For more information about artAI, please visit systechone.com.

About Systech:

Systech provides digital identification and traceability solutions that establish essential product data, ensure digital connectivity, and enable real-time insights on the packaging line and throughout the supply chain. With decades of experience in pharmaceutical packaging execution and serialization, Systech offers comprehensive, easily configured, turnkey software solutions with reliable implementation and expert support. Global brands across industries rely on Systech's platform to help them achieve their objectives in compliance, resiliency, sustainability, and digital transformation. Systech is a leading brand of Markem-Imaje®, a global product identification, packaging intelligence, and connected product solutions provider and a part of Dover Corporation. Visit www.systechone.com for further information.

About Markem-Imaje:

Markem-Imaje, a wholly owned subsidiary of the US-based Dover Corporation is a trusted world manufacturer of product identification and traceability solutions, offering a full line of reliable and innovative inkjet, thermal transfer, laser, and print and apply label systems. Markem-Imaje provides global reach to over 50,000 customers with 30 subsidiaries, 6 technology centers, several equipment repair centers and manufacturing plants with the most comprehensive marking and coding portfolio available in the marketplace. Visit www.markem-imaje.com for further information.

About Dover:

Dover is a diversified global manufacturer and solutions provider with annual revenue of over $7 billion. We deliver innovative equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services through five operating segments: Engineered Products, Clean Energy & Fueling, Imaging & Identification, Pumps & Process Solutions and Climate & Sustainability Technologies. Dover combines global scale with operational agility to lead the markets we serve. Recognized for our entrepreneurial approach for over 70 years, our team of approximately 24,000 employees takes an ownership mindset, collaborating with customers to redefine what's possible. Headquartered in Downers Grove, Illinois, Dover trades on the New York Stock Exchange under "DOV." Additional information is available at dovercorporation.com.

Systech Contact:
Jim Waters
(609) 395-8400
pr@systechone.com

Dover Media Contact:
Adrian Sakowicz, VP, Communications
(630) 743-5039
asakowicz@dovercorp.com

Dover Investor Contact:
Jack Dickens, VP, Investor Relations
(630) 743-2566
jdickens@dovercorp.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/systech-launches-unisecure-artai-an-ai-powered-authentication-solution-for-the-life-sciences-and-pharmaceutical-industries-302386272.html

SOURCE Dover

FAQ

What is the estimated market size of counterfeit medicines that Systech's artAI aims to combat?

According to the National Institutes of Health, the illicit, fraudulent, or substandard drug market generates up to $432 billion annually.

How does Systech's new artAI solution protect pharmaceutical products?

artAI creates digital blueprints of packaging artwork using AI, machine vision, and machine learning for authentication and quality inspection, enabling real-time verification through pattern recognition.

What are the key operational benefits of Systech's artAI for pharmaceutical companies?

artAI offers fast deployment without hardware integration, real-time detection, forensic intelligence, retroactive/proactive protection, and reduced carbon footprint through centralized operations.

Does Systech's artAI require changes to existing product packaging?

No, artAI uses existing packaging artwork and requires no packaging changes, allowing for immediate deployment and value generation.